13-23335023-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_014363.6(SACS):​c.8853T>C​(p.Val2951Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.262 in 1,613,350 control chromosomes in the GnomAD database, including 58,049 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. V2951V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.23 ( 4559 hom., cov: 33)
Exomes 𝑓: 0.27 ( 53490 hom. )

Consequence

SACS
NM_014363.6 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: 0.156

Publications

19 publications found
Variant links:
Genes affected
SACS (HGNC:10519): (sacsin molecular chaperone) This gene encodes the sacsin protein, which includes a UbL domain at the N-terminus, a DnaJ domain, and a HEPN domain at the C-terminus. The gene is highly expressed in the central nervous system, also found in skin, skeletal muscles and at low levels in the pancreas. This gene includes a very large exon spanning more than 12.8 kb. Mutations in this gene result in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), a neurodegenerative disorder characterized by early-onset cerebellar ataxia with spasticity and peripheral neuropathy. The authors of a publication on the effects of siRNA-mediated sacsin knockdown concluded that sacsin protects against mutant ataxin-1 and suggest that "the large multi-domain sacsin protein is able to recruit Hsp70 chaperone action and has the potential to regulate the effects of other ataxia proteins" (Parfitt et al., PubMed: 19208651). A pseudogene associated with this gene is located on chromosome 11. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
SACS Gene-Disease associations (from GenCC):
  • Charlevoix-Saguenay spastic ataxia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, PanelApp Australia, G2P, Myriad Women’s Health, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 13-23335023-A-G is Benign according to our data. Variant chr13-23335023-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 130205.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.156 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.34 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014363.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SACS
NM_014363.6
MANE Select
c.8853T>Cp.Val2951Val
synonymous
Exon 10 of 10NP_055178.3
SACS
NM_001437336.1
c.8880T>Cp.Val2960Val
synonymous
Exon 11 of 11NP_001424265.1A0A804HIQ1
SACS
NM_001278055.2
c.8412T>Cp.Val2804Val
synonymous
Exon 8 of 8NP_001264984.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SACS
ENST00000382292.9
TSL:5 MANE Select
c.8853T>Cp.Val2951Val
synonymous
Exon 10 of 10ENSP00000371729.3Q9NZJ4-1
SACS
ENST00000455470.6
TSL:1
c.2432-5539T>C
intron
N/AENSP00000406565.2H0Y6M8
SACS
ENST00000682944.1
c.8880T>Cp.Val2960Val
synonymous
Exon 11 of 11ENSP00000507173.1A0A804HIQ1

Frequencies

GnomAD3 genomes
AF:
0.226
AC:
34398
AN:
152080
Hom.:
4556
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0914
Gnomad AMI
AF:
0.167
Gnomad AMR
AF:
0.326
Gnomad ASJ
AF:
0.401
Gnomad EAS
AF:
0.338
Gnomad SAS
AF:
0.356
Gnomad FIN
AF:
0.235
Gnomad MID
AF:
0.301
Gnomad NFE
AF:
0.257
Gnomad OTH
AF:
0.256
GnomAD2 exomes
AF:
0.287
AC:
71940
AN:
250780
AF XY:
0.288
show subpopulations
Gnomad AFR exome
AF:
0.0885
Gnomad AMR exome
AF:
0.388
Gnomad ASJ exome
AF:
0.401
Gnomad EAS exome
AF:
0.350
Gnomad FIN exome
AF:
0.246
Gnomad NFE exome
AF:
0.257
Gnomad OTH exome
AF:
0.278
GnomAD4 exome
AF:
0.266
AC:
388691
AN:
1461152
Hom.:
53490
Cov.:
40
AF XY:
0.268
AC XY:
195147
AN XY:
726852
show subpopulations
African (AFR)
AF:
0.0856
AC:
2859
AN:
33416
American (AMR)
AF:
0.378
AC:
16896
AN:
44672
Ashkenazi Jewish (ASJ)
AF:
0.402
AC:
10481
AN:
26094
East Asian (EAS)
AF:
0.345
AC:
13702
AN:
39686
South Asian (SAS)
AF:
0.341
AC:
29430
AN:
86220
European-Finnish (FIN)
AF:
0.239
AC:
12738
AN:
53364
Middle Eastern (MID)
AF:
0.326
AC:
1879
AN:
5762
European-Non Finnish (NFE)
AF:
0.256
AC:
284949
AN:
1111574
Other (OTH)
AF:
0.261
AC:
15757
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
17277
34554
51831
69108
86385
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9810
19620
29430
39240
49050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.226
AC:
34413
AN:
152198
Hom.:
4559
Cov.:
33
AF XY:
0.231
AC XY:
17215
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.0915
AC:
3801
AN:
41550
American (AMR)
AF:
0.326
AC:
4985
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.401
AC:
1392
AN:
3470
East Asian (EAS)
AF:
0.339
AC:
1753
AN:
5178
South Asian (SAS)
AF:
0.354
AC:
1710
AN:
4824
European-Finnish (FIN)
AF:
0.235
AC:
2497
AN:
10606
Middle Eastern (MID)
AF:
0.303
AC:
89
AN:
294
European-Non Finnish (NFE)
AF:
0.257
AC:
17489
AN:
67960
Other (OTH)
AF:
0.258
AC:
545
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1323
2646
3970
5293
6616
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
368
736
1104
1472
1840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.258
Hom.:
8961
Bravo
AF:
0.230
Asia WGS
AF:
0.317
AC:
1103
AN:
3478
EpiCase
AF:
0.265
EpiControl
AF:
0.268

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
not specified (7)
-
-
3
Charlevoix-Saguenay spastic ataxia (3)
-
-
3
not provided (3)
-
-
1
Hereditary spastic paraplegia (1)
-
-
1
Spastic paraplegia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.72
CADD
Benign
0.45
DANN
Benign
0.62
PhyloP100
0.16
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9552929; hg19: chr13-23909162; COSMIC: COSV104428861; API